EUROCOMMERCIAL, WEBSTEP, Another 8 Companies Have A High Estimated Dividend Yield

(VIANEWS) – EUROCOMMERCIAL (ECMPA.AS), WEBSTEP (WSTEP.OL), HAULOTTE GROUP (PIG.PA) have the highest dividend yield stocks on this list.

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. EUROCOMMERCIAL (ECMPA.AS)

14.73% Foward Dividend Yield

EUROCOMMERCIAL’s last close was €21.04, 12.77% under its 52-week high of €24.12. Intraday change was -0.57%.

Eurocommercial Properties N.V. is a Euronext-quoted property investment company and one of Europe's shopping centre specialists. Founded in 1991, Eurocommercial currently owns and operates 24 shopping centres in Belgium, France, Italy, and Sweden with total assets of almost 3.8 billion Euro.

Earnings Per Share

As for profitability, EUROCOMMERCIAL has a trailing twelve months EPS of €0.7.

PE Ratio

EUROCOMMERCIAL has a trailing twelve months price to earnings ratio of 29.89. Meaning, the purchaser of the share is investing €29.89 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.73%.

Volatility

EUROCOMMERCIAL’s last week, last month’s, and last quarter’s current intraday variation average was 0.03%, 0.28%, and 1.24%.

EUROCOMMERCIAL’s highest amplitude of average volatility was 0.26% (last week), 1.47% (last month), and 1.24% (last quarter).

Volume

Today’s last reported volume for EUROCOMMERCIAL is 3589 which is 90.44% below its average volume of 37569.

Moving Average

EUROCOMMERCIAL’s worth is higher than its 50-day moving average of €20.70 and under its 200-day moving average of €21.61.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.8%, now sitting on 255.97M for the twelve trailing months.

More news about EUROCOMMERCIAL.

2. WEBSTEP (WSTEP.OL)

8.54% Foward Dividend Yield

WEBSTEP’s last close was kr19.90, 37.62% below its 52-week high of kr31.90. Intraday change was -0.25%.

Webstep ASA, together with its subsidiaries, provides information technology (IT) consultancy services to public and private businesses in Norway and Sweden. The company offers digitalization, cloud migration and integration, Internet of Things, machine learning, IT security, robotics, and analytics. Its services include consulting, digitalization, .Net, Java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, Devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, Beacons, enterprise user experience, web analysis, design team, Amazon Web, Azure, prediction, AI, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. The company serves banking, finance and insurance, public administration, agriculture and food production, IT and telecommunication, commerce, and transportation industries. The company was founded in 2000 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, WEBSTEP has a trailing twelve months EPS of kr1.42.

PE Ratio

WEBSTEP has a trailing twelve months price to earnings ratio of 13.98. Meaning, the purchaser of the share is investing kr13.98 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.27%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 984.34M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, WEBSTEP’s stock is considered to be overbought (>=80).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 5, 2023, the estimated forward annual dividend rate is 1.7 and the estimated forward annual dividend yield is 8.54%.

More news about WEBSTEP.

3. HAULOTTE GROUP (PIG.PA)

6.61% Foward Dividend Yield

HAULOTTE GROUP’s last close was €2.47, 35.76% under its 52-week high of €3.85. Intraday change was -1.98%.

Haulotte Group SA, through its subsidiaries, designs, manufactures, and markets people and material lifting equipment. Its products include people lifting equipment comprising push-arounds, vertical masts, scissor lifts, articulating and telescopic booms, trailer mounted booms, and self-propelled booms. The company also provides shield bars, lighting systems, emission systems, and screens, as well as apps for the lifting equipment. In addition, it offers spare parts; provides training, repair, and financing services; and rents lifting equipment. The company markets and sells its products in Europe, the Asia Pacific, North America, and Latin America. It provides solutions for civil and military applications; rental companies; and logistics, manufacturing, airport operations, maintenance, and retail sectors. The company was founded in 1881 and is based in Lorette, France. Haulotte Group SA is a subsidiary of Solem S.A.

Earnings Per Share

As for profitability, HAULOTTE GROUP has a trailing twelve months EPS of €-0.53.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.52%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAULOTTE GROUP’s stock is considered to be overbought (>=80).

More news about HAULOTTE GROUP.

4. GIMV (GIMB.BR)

5.98% Foward Dividend Yield

GIMV’s last close was €43.45, 8.81% below its 52-week high of €47.65. Intraday change was 0.46%.

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to €125 million ($144.76 million). It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies with headquarters in Benelux, France and DACH region. It typically makes investments between €3 million ($3.47 million) to €10 million ($11.58 million) in the biopharma and medtech and between €10 million ($11.58 million) to €30 million ($34.74 million) in the health and care services. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering, advanced manufacturing or software. It invests in companies with an enterprise value of up to €125 million ($144.76 million). It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. It seeks to invest in small to medium companies with headquarters in the Benelux, France and Germany (DACH) targeting an international customer base. For fund of fund investments, it seeks to invest in Europe. It typically invests between $2.9 million and $425.439 million in companies with an enterprise value between $86.85 million and $868.55 million and sales value ranging from $6.67 million to $567.252 million. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.

Earnings Per Share

As for profitability, GIMV has a trailing twelve months EPS of €6.41.

PE Ratio

GIMV has a trailing twelve months price to earnings ratio of 6.81. Meaning, the purchaser of the share is investing €6.81 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.99%.

Volatility

GIMV’s last week, last month’s, and last quarter’s current intraday variation average was 2.62%, 0.85%, and 1.07%.

GIMV’s highest amplitude of average volatility was 2.62% (last week), 1.54% (last month), and 1.07% (last quarter).

More news about GIMV.

5. SERGEFERRARI GROUP (SEFER.PA)

5.95% Foward Dividend Yield

SERGEFERRARI GROUP’s last close was €7.24, 54.75% under its 52-week high of €16.00. Intraday change was -0.69%.

SergeFerrari Group SA designs, develops, manufactures, and markets composite materials for lightweight architectural and outdoor applications in France and internationally. It provides its products for solar protection, tensile architecture, modular structures, and furniture/marine markets. The company offers solutions for indoor and outdoor blind, and terrace blind and awning; tensile roof and shading structure; indoor and outdoor acoustic treatment; bioclimatic façade, including building construction and renovation; and waterproof breathable membrane applications. It also provides products and solutions for modular structure, visual communication for printed advertisement, protection, environment, and yachting applications. In addition, the company offers outdoor sling seats and membranes for garden furniture; and upholstery for indoor and outdoor furniture. The company was founded in 1973 and is headquartered in Saint-Jean-de-Soudain, France.

Earnings Per Share

As for profitability, SERGEFERRARI GROUP has a trailing twelve months EPS of €0.88.

PE Ratio

SERGEFERRARI GROUP has a trailing twelve months price to earnings ratio of 8.17. Meaning, the purchaser of the share is investing €8.17 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.9%.

Volatility

SERGEFERRARI GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.37%, a positive 1.69%, and a positive 2.99%.

SERGEFERRARI GROUP’s highest amplitude of average volatility was 2.16% (last week), 3.56% (last month), and 2.99% (last quarter).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 5.95%.

More news about SERGEFERRARI GROUP.

6. AKER (AKER.OL)

4.55% Foward Dividend Yield

AKER’s last close was kr671.50, 16.79% below its 52-week high of kr807.00. Intraday change was -0.07%.

Aker ASA operates as an industrial investment company in Norway, the European Union, North America, South America, Asia, and internationally. It operates in two segments, Industrial Holdings and Financial Investments. The company engages in the exploration and production of oil and gas; provides solutions, products, and services to the energy industry; develops and delivers technologies to drilling market; holds oil reserves; and harvests, develops, markets, and sells krill-based ingredients and product for nutraceutical, aquaculture, and animal feed applications. It also focuses on renewable energy and green technologies; builds and operates sea-based salmon farming; offers Cognite Data Fusion that collects, processes, and facilitates big data for its industry customers; designs, constructs, and leases vessels; owns and operates supply-vessels, anchor handling vessels, and construction service vessels; trades in financial instruments; operates platform for venture capital in industrial technology; develops real estate and software; acts as an investment manager; and invests in bitcoin, and projects and companies throughout the bitcoin ecosystem. The company was founded in 1841 and is based in Lysaker, Norway. Aker ASA is a subsidiary of TRG Holding AS.

Earnings Per Share

As for profitability, AKER has a trailing twelve months EPS of kr-39.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.1%.

Yearly Top and Bottom Value

AKER’s stock is valued at kr671.00 at 01:50 EST, way below its 52-week high of kr807.00 and way higher than its 52-week low of kr575.00.

More news about AKER.

7. CRCAM TOURAINE CCI (CRTO.PA)

4.43% Foward Dividend Yield

CRCAM TOURAINE CCI’s last close was €79.00, 8.67% under its 52-week high of €86.50. Intraday change was 1.9%.

Caisse Régionale de Crédit Agricole Mutuel de La Touraine et du Poitou Société Coopérative provides various banking products and services in France. It offers bank accounts and cards, savings products, real estate and agricultural loans, and other financial services, as well as car and two-wheeler, health and death, personal, borrower leisure and daily life, and home insurance products. The company also provides consumer credit comprising personal, car, and student and apprentice loans; and foreign exchange, real estate investment, cash management, business creation financing, leasing, medium-term credit, and financial investment services, as well as collection and treasury solutions. It serves individuals, private bank, professionals, farmers, businesses, associations, and public community and social housing customers. The company was incorporated in 1995 and is based in Poitiers, France. Caisse Régionale de Crédit Agricole Mutuel de La Touraine et du Poitou Société Coopérative operates as a subsidiary of Crédit Agricole S.A.

Earnings Per Share

As for profitability, CRCAM TOURAINE CCI has a trailing twelve months EPS of €16.16.

PE Ratio

CRCAM TOURAINE CCI has a trailing twelve months price to earnings ratio of 4.98. Meaning, the purchaser of the share is investing €4.98 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.02%.

More news about CRCAM TOURAINE CCI.

8. SANOFI (SAN.PA)

4.12% Foward Dividend Yield

SANOFI’s last close was €86.38, 17.87% below its 52-week high of €105.18. Intraday change was 0.95%.

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, SANOFI has a trailing twelve months EPS of €7.22.

PE Ratio

SANOFI has a trailing twelve months price to earnings ratio of 12.08. Meaning, the purchaser of the share is investing €12.08 for every euro of annual earnings.

Sales Growth

SANOFI’s sales growth is 4.2% for the ongoing quarter and 0.3% for the next.

More news about SANOFI.

9. AHOLD DEL (AD.AS)

4.02% Foward Dividend Yield

AHOLD DEL’s last close was €26.90, 17.26% under its 52-week high of €32.51. Intraday change was -0.33%.

Koninklijke Ahold Delhaize N.V. operates retail food stores and e-commerce primarily in the United States and Europe. The company's stores offer produce, dairy, meat, deli, bakery, seafood, and frozen products; grocery, dairy, and beer and wine; floral, pet food, health and beauty care, kitchen and cookware, gardening tools, general merchandise articles, electronics, newspapers and magazines, tobacco, etc.; gasoline; and pharmacy products. It operates its supermarkets, convenience stores, and online stores under the Food Lion, Stop & Shop, The GIANT Company, Hannaford, Giant Food, FreshDirect, Albert Heijn, bol.com, Etos, Gall & Gall, Delhaize, Albert, Alfa Beta Vassilopoulos, Mega Image, and Delhaize Serbia brands. The company was formerly known as Koninklijke Ahold N.V. and changed its name to Koninklijke Ahold Delhaize N.V. in July 2016. Koninklijke Ahold Delhaize N.V. was founded in 1867 and is headquartered in Zaandam, the Netherlands.

Earnings Per Share

As for profitability, AHOLD DEL has a trailing twelve months EPS of €2.28.

PE Ratio

AHOLD DEL has a trailing twelve months price to earnings ratio of 11.76. Meaning, the purchaser of the share is investing €11.76 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.26%.

More news about AHOLD DEL.

10. MEDISTIM (MEDI.OL)

2.25% Foward Dividend Yield

MEDISTIM’s last close was kr200.00, 36% below its 52-week high of kr312.50. Intraday change was -1.46%.

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.41.

PE Ratio

MEDISTIM has a trailing twelve months price to earnings ratio of 31.67. Meaning, the purchaser of the share is investing kr31.67 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.37%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 526.89M for the twelve trailing months.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 2.25%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEDISTIM’s stock is considered to be overbought (>=80).

Moving Average

MEDISTIM’s worth is higher than its 50-day moving average of kr202.38 and way under its 200-day moving average of kr242.62.

More news about MEDISTIM.